UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:August 19,
Aptevo Therapeutics (NASDAQ:APVO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Aptevo Therapeutics Charts.
Aptevo Therapeutics (NASDAQ:APVO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Aptevo Therapeutics Charts.

Aptevo Therapeutics Inc. News

Form 8-K - Current report
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 31 January 2024 (3 months ago) • Edgar (US Regulatory)
Form DEFR14A - Revised definitive proxy soliciting materials
Wednesday 31 January 2024 (3 months ago) • Edgar (US Regulatory)
Form DEFR14A - Revised definitive proxy soliciting materials
Wednesday 17 January 2024 (3 months ago) • Edgar (US Regulatory)
Form DEF 14A - Other definitive proxy statements
Saturday 23 December 2023 (4 months ago) • Edgar (US Regulatory)
Form PRE 14A - Other preliminary proxy statements
Wednesday 13 December 2023 (4 months ago) • Edgar (US Regulatory)

More Aptevo Therapeutics Inc. News Articles